Home/Filings/4/0001415889-25-001368
4//SEC Filing

Schiller Mark C. 4

Accession 0001415889-25-001368

CIK 0001645666other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 4:15 PM ET

Size

5.5 KB

Accession

0001415889-25-001368

Insider Transaction Report

Form 4
Period: 2025-01-09
Schiller Mark C.
Chief Legal Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-01-09+24,50024,500 total
    Exercise: $6.58Exp: 2035-01-08Common Stock (24,500 underlying)
Footnotes (1)
  • [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on February 9, 2025, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Kezar Life Sciences, Inc.

CIK 0001645666

Entity typeother

Related Parties

1
  • filerCIK 0002007659

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:15 PM ET
Size
5.5 KB